Does FOSCARBIDOPA\FOSLEVODOPA Cause Infusion site erythema? 157 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 157 reports of Infusion site erythema have been filed in association with FOSCARBIDOPA\FOSLEVODOPA. This represents 5.0% of all adverse event reports for FOSCARBIDOPA\FOSLEVODOPA.
157
Reports of Infusion site erythema with FOSCARBIDOPA\FOSLEVODOPA
5.0%
of all FOSCARBIDOPA\FOSLEVODOPA reports
8
Deaths
84
Hospitalizations
How Dangerous Is Infusion site erythema From FOSCARBIDOPA\FOSLEVODOPA?
Of the 157 reports, 8 (5.1%) resulted in death, 84 (53.5%) required hospitalization, and 3 (1.9%) were considered life-threatening.
Is Infusion site erythema Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FOSCARBIDOPA\FOSLEVODOPA. However, 157 reports have been filed with the FAERS database.
What Other Side Effects Does FOSCARBIDOPA\FOSLEVODOPA Cause?
On and off phenomenon (391)
Fall (343)
Hallucination (293)
Dyskinesia (237)
Death (203)
General physical health deterioration (173)
Mobility decreased (154)
Infusion site pain (143)
Malaise (139)
Tremor (133)
What Other Drugs Cause Infusion site erythema?
TREPROSTINIL (2,990)
HUMAN IMMUNOGLOBULIN G (1,850)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE (312)
AMBRISENTAN (308)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN (213)
MACITENTAN (147)
EPOPROSTENOL (90)
RIOCIGUAT (80)
LECITHIN\POLOXAMER 407 (70)
INFLIXIMAB-DYYB (62)
Which FOSCARBIDOPA\FOSLEVODOPA Alternatives Have Lower Infusion site erythema Risk?
FOSCARBIDOPA\FOSLEVODOPA vs FOSCARNET
FOSCARBIDOPA\FOSLEVODOPA vs FOSFOMYCIN
FOSCARBIDOPA\FOSLEVODOPA vs FOSFOMYCIN TROMETHAMINE
FOSCARBIDOPA\FOSLEVODOPA vs FOSINOPRIL
FOSCARBIDOPA\FOSLEVODOPA vs FOSPHENYTOIN